Two case reports of oral ulcers with lamotrigine several weeks after oxcarbazepine withdrawal

Bipolar Disorders

Volumn 9, Issue 3, 2007, Pages 310-313

  O'neill, Amy ^a   De Leon, Jose ^a,b  

^a Eastern State Hospital   (United States)

^b M Hlth Res Ctr at E State Hosp   (United States)

Author keywords

Bipolar disorder; Carbamazepine analog sand derivates; Enzyme induction; Lamotrigine; Oral ulcers; Oxcarbazepine; Stevens Johnson syndrome

Indexed keywords

AMOXICILLIN; ARIPIPRAZOLE; CARBAMAZEPINE; ESCITALOPRAM; FAMOTIDINE; FLUOXETINE; GLUCURONOSYLTRANSFERASE; HYDROXYZINE; LAMOTRIGINE; LEVOTHYROXINE; LITHIUM CARBONATE; METOPROLOL; MIRTAZAPINE; NAPROXEN; OXCARBAZEPINE; PANTOPRAZOLE; PHENYTOIN; PROPRANOLOL; QUETIAPINE; TOPIRAMATE; VENLAFAXINE;

ADULT; ARTICLE; ASTHMA; AWARENESS; BIPOLAR II DISORDER; CASE REPORT; COMORBIDITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG METABOLISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME INDUCTION; FEMALE; GASTRITIS; GASTROESOPHAGEAL REFLUX; GLUCURONIDATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERTENSION; HYPOTHYROIDISM; MALE; MOUTH ULCER; OUTPATIENT CARE; PRIORITY JOURNAL; PSYCHIATRIST; RISK ASSESSMENT; SEIZURE; SUICIDAL BEHAVIOR;

ADULT; BIPOLAR DISORDER; CARBAMAZEPINE; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; FEMALE; HUMANS; MALE; ORAL ULCER; TRIAZINES;

EID: 34047256115     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2007.00392.x     Document Type: Article

References (13)

1. GlaxoSmithKline. Lamictal Prescribing Information. Research Triangle Park, NC: GlaxoSmithKline, 2005. http://us.gsk.com/products/assets/ us_lamictal.pdf. (Accessed November 3, 2006).
2. Roujeau JC, Stern RS. Severe cutaneous adverse reactions to drugs. N Engl J Med 1994; 331: 1272-1285.
3. Messenheimer JA. Rash in adult and pediatric patients treated with lamotrigine. Can J Neurol Sci 1998; 25: 514-518.
4. Wong IC, Mawer GE, Sander JW. Factors influencing the incidence of lamotrigine-related skin rash. Ann Pharmacother 1999; 33: 1037-1042.
5. Calabrese JR, Sullivan JR, Bowden CL et al. Rash in multicenter trials of lamotrigine in mood disorders: Clinical relevance and management. J Clin Psychiatry 2002; 63: 1012-1019.
6. Bastuji-Garin S, Rzany B, Stern RS. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome and erythema multiforme. Arch Dermatol 1993;129: 92-96.
7. Burchell B, Soars M, Monaghan G et al. Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases. Toxicol Lett 2000; 112-113: 333-340.
8. de Leon J. Glucuronidation enzyme genes and psychiatry. Int J Neuropsychopharmacol 2003; 6: 57-72.
9. Novartis Pharmaceuticals Corporation. Trileptal Prescribing Information. East Hanover, NJ: Novartis Pharmaceuticals Corporation, 2005 http://www.pharma.us.novartis.com/product/pi/pdf/trileptal.pdf. (Accessed November 3, 2006).
10. Baird P. The interactive metabolism effect of oxcarbazepine coadministered with tricyclic antidepressant therapy for OCD symptoms. J Clin Psychopharmacol 2003; 23: 419-420.
11. de Leon J. Atypical antipsychotic dosing: The effect of co-medication with anticonvulsants. Psychiatr Serv 2004; 55: 125-128.
12. Surja AS, Brotzge KE, El-Mallakh Rif S. Serious rash with lamotrigine after carbamazepine discontinuation: A case report. J Clin Psychiatry 2005; 66: 400-401.
13. May TW, Rambeck B, Jurgens U et al. Influence of oxcarbamazepine and methosuximide on lamotrigine concentrations in epileptic patients with and without valproic acid comedication: Results of a retrospective study. Ther Drug Monit 1999; 21: 175-181.